{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:25:47Z","timestamp":1792121147178,"version":"4.4.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR071439"],"award-info":[{"award-number":["R01 AR071439"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR055299"],"award-info":[{"award-number":["R01 AR055299"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Skeletal Muscle"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Defects in \u03b1-dystroglycan (DG) glycosylation characterize a group of muscular dystrophies known as dystroglycanopathies. One of the key effectors in the \u03b1-DG glycosylation pathway is the glycosyltransferase fukutin-related protein (FKRP). Mutations in <jats:italic>FKRP<\/jats:italic> lead to a large spectrum of muscular dystrophies, including limb girdle muscular dystrophy 2I (LGMD2I). It remains unknown whether stem cell transplantation can promote muscle regeneration and ameliorate the muscle wasting phenotype associated with <jats:italic>FKRP<\/jats:italic> mutations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Here we transplanted murine and human pluripotent stem cell-derived myogenic progenitors into a novel immunodeficient <jats:italic>FKRP<\/jats:italic>-mutant mouse model by intra-muscular injection. Upon both mouse and human cell transplantation, we observe the presence of donor-derived myofibers even in absence of pre-injury, and the rescue of \u03b1-DG functional glycosylation, as shown by IIH6 immunoreactivity. The presence of donor-derived cells expressing Pax7 under the basal lamina is indicative of satellite cell engraftment, and therefore, long-term repopulation potential. Functional assays performed in the mouse-to-mouse cohort revealed enhanced specific force in transplanted muscles compared to PBS-injected controls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Altogether, our data demonstrate for the first time the suitability of a cell-based therapeutic approach to improve the muscle phenotype of dystrophic <jats:italic>FKRP<\/jats:italic>-mutant mice.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13395-020-00228-3","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T09:03:28Z","timestamp":1587546208000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Efficient engraftment of pluripotent stem cell-derived myogenic progenitors in a novel immunodeficient mouse model of limb girdle muscular dystrophy 2I"],"prefix":"10.1186","volume":"10","author":[{"given":"Karim","family":"Azzag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Ortiz-Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelio A. J.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Magli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar","family":"Selvaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudheer","family":"Tungtur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weston","family":"Upchurch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Iaizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi Long","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita C. R.","family":"Perlingeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,22]]},"reference":[{"issue":"3","key":"228_CR1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.gde.2011.02.001","volume":"21","author":"C Godfrey","year":"2011","unstructured":"Godfrey C, Foley AR, Clement E, Muntoni F. Dystroglycanopathies: coming into focus. Curr Opin Genet Dev. 2011;21(3):278\u201385.","journal-title":"Curr Opin Genet Dev."},{"issue":"2","key":"228_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1242\/jcs.02814","volume":"119","author":"R Barresi","year":"2006","unstructured":"Barresi R. Dystroglycan: from biosynthesis to pathogenesis of human disease. J Cell Sci. 2006;119(2):199\u2013207.","journal-title":"J Cell Sci."},{"issue":"6","key":"228_CR3","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/0092-8674(91)90035-W","volume":"66","author":"JM Ervasti","year":"1991","unstructured":"Ervasti JM, Campbell KP. Membrane organization of the dystrophin-glycoprotein complex. Cell. 1991 Sep;66(6):1121\u201331.","journal-title":"Cell."},{"issue":"4","key":"228_CR4","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1083\/jcb.122.4.809","volume":"122","author":"JM Ervasti","year":"1993","unstructured":"Ervasti JM. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol. 1993;122(4):809\u201323.","journal-title":"J Cell Biol."},{"key":"228_CR5","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/0092-8674(94)90052-3","volume":"77","author":"H Gee","year":"1994","unstructured":"Gee H, Llndenbaum H. Dystroglycan-u, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell. 1994;77:675\u201386.","journal-title":"Cell."},{"issue":"11","key":"228_CR6","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1007\/s10038-006-0056-7","volume":"51","author":"M Kanagawa","year":"2006","unstructured":"Kanagawa M, Toda T. The genetic and molecular basis of muscular dystrophy: roles of cell\u2013matrix linkage in the pathogenesis. J Hum Genet. 2006;51(11):915\u201326.","journal-title":"J Hum Genet."},{"issue":"2","key":"228_CR7","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1083\/jcb.200105003","volume":"154","author":"JF Talts","year":"2001","unstructured":"Talts JF, Andac Z, Brancaccio A, Timpl R. \u03b1-dystroglycan and several extracellular matrix. J Cell Biol. 2001;154(2):435\u201346.","journal-title":"J Cell Biol."},{"issue":"2","key":"228_CR8","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1083\/jcb.200105003","volume":"154","author":"S Sugita","year":"2001","unstructured":"Sugita S, Saito F, Tang J, Satz J, Campbell K, S\u00fcdhof TC. A stoichiometric complex of neurexins and dystroglycan in brain. J Cell Biol. 2001;154(2):435\u201346.","journal-title":"J Cell Biol."},{"issue":"6896","key":"228_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nature00837","volume":"418","author":"DE Michele","year":"2002","unstructured":"Michele DE, Barresi R, Kanagawa M, Saito F, Cohn RD, Satz JS, et al. Post-translational disruption of dystroglycan\u2013ligand interactions in congenital muscular dystrophies. Nature. 2002;418(6896):417\u201321.","journal-title":"Nature."},{"issue":"10","key":"228_CR10","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.nmd.2016.08.012","volume":"26","author":"I Richard","year":"2016","unstructured":"Richard I, Laurent J-P, Cirak S, Vissing J, Brown S, Campbell K, et al. 216th ENMC international workshop: clinical readiness in FKRP related myopathies January 15\u201317, 2016 Naarden. The Netherlands. Neuromuscul Disord. 2016;26(10):717\u201324.","journal-title":"The Netherlands. Neuromuscul Disord."},{"key":"228_CR11","doi-asserted-by":"publisher","first-page":"11534","DOI":"10.1038\/ncomms11534","volume":"7","author":"I Gerin","year":"2016","unstructured":"Gerin I, Ury B, Breloy I, Bouchet-Seraphin C, Bols\u00e9e J, Halbout M, et al. ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto \u03b1-dystroglycan. Nat Commun. 2016;7:11534.","journal-title":"Nat Commun."},{"issue":"9","key":"228_CR12","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1016\/j.celrep.2016.02.017","volume":"14","author":"M Kanagawa","year":"2016","unstructured":"Kanagawa M, Kobayashi K, Tajiri M, Manya H, Kuga A, Yamaguchi Y, et al. Identification of a post-translational modification with ribitol-phosphate and its defect in muscular dystrophy. Cell Rep. 2016;14(9):2209\u201323.","journal-title":"Cell Rep."},{"issue":"25","key":"228_CR13","first-page":"2851","volume":"10","author":"M Brockington","year":"2001","unstructured":"Brockington M, Blake DJ, Prandini P, Brown SC, Torelli S, Benson MA, et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin a2 deficiency and abnormal glycosylation of a-dystroglycan. Am J Hum Genet. 2001;10(25):2851\u20139.","journal-title":"Am J Hum Genet."},{"issue":"5","key":"228_CR14","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1136\/jmg.2003.013870","volume":"41","author":"D Beltran-Valero de Bernabe","year":"2004","unstructured":"Beltran-Valero de Bernabe D. Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome. J Med Genet. 2004;41(5):e61.","journal-title":"J Med Genet."},{"issue":"2","key":"228_CR15","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0002-9440(10)63160-4","volume":"164","author":"SC Brown","year":"2004","unstructured":"Brown SC, Torelli S, Brockington M, Yuva Y, Jimenez C, Feng L, et al. Abnormalities in \u03b1-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies. Am J Pathol. 2004;164(2):727\u201337.","journal-title":"Am J Pathol."},{"issue":"1","key":"228_CR16","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1038\/s41467-018-05990-z","volume":"9","author":"MP Cataldi","year":"2018","unstructured":"Cataldi MP, Lu P, Blaeser A, Lu QL. Ribitol restores functionally glycosylated \u03b1-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice. Nat Commun. 2018;9(1):3448.","journal-title":"Nat Commun."},{"issue":"10","key":"228_CR17","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1038\/mt.2013.156","volume":"21","author":"L Xu","year":"2013","unstructured":"Xu L, Lu PJ, Wang C-H, Keramaris E, Qiao C, Xiao B, et al. Adeno-associated virus 9 mediated FKRP gene therapy restores functional glycosylation of \u03b1-dystroglycan and improves muscle functions. Mol Ther J Am Soc Gene Ther. 2013;21(10):1832\u201340.","journal-title":"Mol Ther J Am Soc Gene Ther."},{"issue":"11","key":"228_CR18","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1038\/mt.2014.141","volume":"22","author":"C Qiao","year":"2014","unstructured":"Qiao C, Wang C-H, Zhao C, Lu P, Awano H, Xiao B, et al. Muscle and heart function restoration in a limb girdle muscular dystrophy 2I (LGMD2I) mouse model by systemic FKRP gene delivery. Mol Ther. 2014;22(11):1890\u20139.","journal-title":"Mol Ther."},{"issue":"10","key":"228_CR19","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1093\/hmg\/ddx066","volume":"26","author":"E Gicquel","year":"2017","unstructured":"Gicquel E, Maizonnier N, Foltz SJ, Martin WJ, Bourg N, Svinartchouk F, et al. AAV-mediated transfer of FKRP shows therapeutic efficacy in a murine model but requires control of gene expression. Hum Mol Genet. 2017;26(10):1952\u201365.","journal-title":"Hum Mol Genet."},{"key":"228_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.omtm.2017.02.002","volume":"5","author":"CH Vannoy","year":"2017","unstructured":"Vannoy CH, Xiao W, Lu P, Xiao X, Lu QL. Efficacy of gene therapy is dependent on disease progression in dystrophic mice with mutations in the FKRP gene. Mol Ther - Methods Clin Dev. 2017;5:31\u201342.","journal-title":"Mol Ther - Methods Clin Dev."},{"issue":"19","key":"228_CR21","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1093\/hmg\/ddx252","volume":"26","author":"P Frattini","year":"2017","unstructured":"Frattini P, Villa C, De Santis F, Meregalli M, Belicchi M, Erratico S, et al. Autologous intramuscular transplantation of engineered satellite cells induces exosome-mediated systemic expression of fukutin-related protein and rescues disease phenotype in a murine model of limb-girdle muscular dystrophy type 2I. Hum Mol Genet. 2017;26(19):3682\u201398.","journal-title":"Hum Mol Genet."},{"issue":"4","key":"228_CR22","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/j.ajpath.2017.12.011","volume":"188","author":"B Wu","year":"2018","unstructured":"Wu B, Shah SN, Lu P, Bollinger LE, Blaeser A, Sparks S, et al. Long-term treatment of tamoxifen and raloxifene alleviates dystrophic phenotype and enhances muscle functions of FKRP dystroglycanopathy. Am J Pathol. 2018;188(4):1069\u201380.","journal-title":"Am J Pathol."},{"key":"228_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.omtm.2019.12.005","volume":"17","author":"MP Cataldi","year":"2020","unstructured":"Cataldi MP, Blaeser A, Lu P, Leroy V, Lu QL. ISPD overexpression enhances ribitol-induced glycosylation of \u03b1-dystroglycan in dystrophic FKRP mutant mice. Mol Ther - Methods Clin Dev. 2020;17:271\u201380.","journal-title":"Mol Ther - Methods Clin Dev."},{"issue":"2","key":"228_CR24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nm1705","volume":"14","author":"R Darabi","year":"2008","unstructured":"Darabi R, Gehlbach K, Bachoo RM, Kamath S, Osawa M, Kamm KE, et al. Functional skeletal muscle regeneration from differentiating embryonic stem cells. Nat Med. 2008 Feb;14(2):134\u201343.","journal-title":"Nat Med."},{"issue":"140","key":"228_CR25","doi-asserted-by":"publisher","first-page":"140ra89","DOI":"10.1126\/scitranslmed.3003541","volume":"4","author":"FS Tedesco","year":"2012","unstructured":"Tedesco FS, Gerli MFM, Perani L, Benedetti S, Ungaro F, Cassano M, et al. Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy. Sci Transl Med. 2012;4(140):140ra89.","journal-title":"Sci Transl Med"},{"issue":"1","key":"228_CR26","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1038\/ncomms2550","volume":"4","author":"A Filareto","year":"2013","unstructured":"Filareto A, Parker S, Darabi R, Borges L, Iacovino M, Schaaf T, et al. An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells. Nat Commun. 2013;4(1):1549.","journal-title":"Nat Commun."},{"key":"228_CR27","doi-asserted-by":"crossref","unstructured":"Selvaraj S, Dhoke NR, Kiley J, Mateos-Aierdi AJ, Tungtur S, Mondragon-Gonzalez R, et al. Gene correction of LGMD2A patient-specific iPSCs for the development of targeted autologous cell therapy. Mol Ther. 2019;S1525001619303946.","DOI":"10.1016\/j.ymthe.2019.08.011"},{"issue":"2","key":"228_CR28","doi-asserted-by":"publisher","first-page":"e3000153","DOI":"10.1371\/journal.pbio.3000153","volume":"17","author":"A Magli","year":"2019","unstructured":"Magli A, Baik J, Mills LJ, Kwak I-Y, Dillon BS, Mondragon Gonzalez R, et al. Time-dependent Pax3-mediated chromatin remodeling and cooperation with Six4 and Tead2 specify the skeletal myogenic lineage in developing mesoderm. Becker PB, editor. PLOS Biol. 2019;17(2):e3000153.","journal-title":"PLOS Biol"},{"issue":"5","key":"228_CR29","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.stem.2012.02.015","volume":"10","author":"R Darabi","year":"2012","unstructured":"Darabi R, Arpke RW, Irion S, Dimos JT, Grskovic M, Kyba M, et al. Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice. Cell Stem Cell. 2012;10(5):610\u20139.","journal-title":"Cell Stem Cell."},{"issue":"13","key":"228_CR30","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1016\/j.celrep.2017.06.005","volume":"19","author":"A Magli","year":"2017","unstructured":"Magli A, Incitti T, Kiley J, Swanson SA, Darabi R, Rinaldi F, et al. PAX7 Targets, CD54, Integrin \u03b19\u03b21, and SDC2, allow isolation of human ESC\/iPSC-derived myogenic progenitors. Cell Rep. 2017;19(13):2867\u201377.","journal-title":"Cell Rep."},{"key":"228_CR31","doi-asserted-by":"crossref","unstructured":"Mondragon-Gonzalez R, Azzag K, Selvaraj S, Yamamoto A, Perlingeiro RCR. Transplantation studies reveal internuclear transfer of toxic RNA in engrafted muscles of myotonic dystrophy 1 mice. EBioMedicine. 2019;S2352396419305535.","DOI":"10.1016\/j.ebiom.2019.08.031"},{"key":"228_CR32","doi-asserted-by":"publisher","first-page":"e47970","DOI":"10.7554\/eLife.47970","volume":"8","author":"S Selvaraj","year":"2019","unstructured":"Selvaraj S, Mondragon-Gonzalez R, Xu B, Magli A, Kim H, Lain\u00e9 J, et al. Screening identifies small molecules that enhance the maturation of human pluripotent stem cell-derived myotubes. eLife. 2019;8:e47970.","journal-title":"eLife."},{"issue":"20","key":"228_CR33","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1093\/hmg\/ddq314","volume":"19","author":"YM Chan","year":"2010","unstructured":"Chan YM, Keramaris-Vrantsis E, Lidov HG, Norton JH, Zinchenko N, Gruber HE, et al. fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies. Hum Mol Genet. 2010;19(20):3995\u20134006.","journal-title":"Hum Mol Genet."},{"issue":"2","key":"228_CR34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/(SICI)1097-4598(199902)22:2<174::AID-MUS5>3.0.CO;2-S","volume":"22","author":"JG Gross","year":"1999","unstructured":"Gross JG, Morgan JE. Muscle precursor cells injected into irradiated mdx mouse muscle persist after serial injury. Muscle Nerve. 1999;22(2):174\u201385.","journal-title":"Muscle Nerve."},{"issue":"7","key":"228_CR35","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1074\/jbc.271.7.3817","volume":"271","author":"EA Pall","year":"1996","unstructured":"Pall EA, Bolton KM, Ervasti JM. Differential heparin inhibition of skeletal muscle -dystroglycan binding to laminins. J Biol Chem. 1996;271(7):3817\u201321.","journal-title":"J Biol Chem."},{"issue":"7","key":"228_CR36","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1089\/scd.2015.0289","volume":"25","author":"AM Coughlan","year":"2016","unstructured":"Coughlan AM, Harmon C, Whelan S, O\u2019Brien EC, O\u2019Reilly VP, Crotty P, et al. Myeloid engraftment in humanized mice: impact of granulocyte-colony stimulating factor treatment and transgenic mouse strain. Stem Cells Dev. 2016;25(7):530\u201341.","journal-title":"Stem Cells Dev."},{"issue":"10","key":"228_CR37","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","volume":"174","author":"LD Shultz","year":"2005","unstructured":"Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S, et al. Human lymphoid and myeloid cell development in NOD\/LtSz- scid IL2R \u03b3 null mice engrafted with mobilized human hemopoietic stem cells. J Immunol. 2005;174(10):6477\u201389.","journal-title":"J Immunol."},{"key":"228_CR38","doi-asserted-by":"crossref","unstructured":"Blaeser A, Awano H, Lu P, Lu Q-L. Distinct expression of functionally glycosylated alpha-dystroglycan in muscle and non-muscle tissues of FKRP mutant mice. Fraidenraich D, editor. PLOS ONE. 2018 13(1):e0191016.","DOI":"10.1371\/journal.pone.0191016"},{"issue":"7221","key":"228_CR39","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nature07384","volume":"456","author":"A Sacco","year":"2008","unstructured":"Sacco A, Doyonnas R, Kraft P, Vitorovic S, Blau HM. Self-renewal and expansion of single transplanted muscle stem cells. Nature. 2008 Nov;456(7221):502\u20136.","journal-title":"Nature."},{"issue":"1","key":"228_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13395-015-0036-8","volume":"5","author":"J Meng","year":"2015","unstructured":"Meng J, Bencze M, Asfahani R, Muntoni F, Morgan JE. The effect of the muscle environment on the regenerative capacity of human skeletal muscle stem cells. Skelet Muscle. 2015;5(1):11.","journal-title":"Skelet Muscle."},{"issue":"8","key":"228_CR41","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1002\/stem.1402","volume":"31","author":"RW Arpke","year":"2013","unstructured":"Arpke RW, Darabi R, Mader TL, Zhang Y, Toyama A, Lonetree C, et al. A new immuno-, dystrophin-deficient model, the NSG-mdx4Cv mouse, provides evidence for functional improvement following allogeneic satellite cell transplantation: NSG-mdx4Cv mice: satellite cell transplantation. STEM CELLS. 2013;31(8):1611\u201320.","journal-title":"STEM CELLS."},{"issue":"1","key":"228_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1083\/jcb.201310035","volume":"205","author":"CF Bentzinger","year":"2014","unstructured":"Bentzinger CF, von Maltzahn J, Dumont NA, Stark DA, Wang YX, Nhan K, et al. Wnt7a stimulates myogenic stem cell motility and engraftment resulting in improved muscle strength. J Cell Biol. 2014;205(1):97\u2013111.","journal-title":"J Cell Biol."},{"issue":"2","key":"228_CR43","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.stem.2017.12.010","volume":"22","author":"RN Judson","year":"2018","unstructured":"Judson RN, Quarta M, Oudhoff MJ, Soliman H, Yi L, Chang CK, et al. Inhibition of methyltransferase Setd7 allows the in vitro expansion of myogenic stem cells with improved therapeutic potential. Cell Stem Cell. 2018;22(2):177\u2013190.e7.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"228_CR44","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1634\/stemcells.2008-0503","volume":"27","author":"G Messina","year":"2009","unstructured":"Messina G, Sirabella D, Monteverde S, Galvez BG, Tonlorenzi R, Schnapp E, et al. Skeletal muscle differentiation of embryonic mesoangioblasts requires Pax3 activity. Stem Cells. 2009;27(1):157\u201364.","journal-title":"Stem Cells."},{"issue":"10","key":"228_CR45","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1038\/mt.2013.186","volume":"21","author":"D Vallese","year":"2013","unstructured":"Vallese D, Negroni E, Duguez S, Ferry A, Trollet C, Aamiri A, et al. The Rag2\u2013Il2rb\u2013Dmd\u2013 mouse: a novel dystrophic and immunodeficient model to assess innovating therapeutic strategies for muscular dystrophies. Mol Ther. 2013;21(10):1950\u20137.","journal-title":"Mol Ther."},{"key":"228_CR46","doi-asserted-by":"crossref","unstructured":"Filareto A. Engraftment of ES-derived myogenic progenitors in a severe mouse model of muscular dystrophy. J Stem Cell Res Ther. 2012;10(1).","DOI":"10.4172\/2157-7633.S10-001"},{"issue":"4","key":"228_CR47","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0092-8674(00)80533-4","volume":"90","author":"RM Grady","year":"1997","unstructured":"Grady RM, Teng H, Nichol MC, Cunningham JC, Wilkinson RS, Sanes JR. Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell. 1997 Aug;90(4):729\u201338.","journal-title":"Cell."}],"container-title":["Skeletal Muscle"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-020-00228-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13395-020-00228-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-020-00228-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T00:08:54Z","timestamp":1619050134000},"score":1,"resource":{"primary":{"URL":"https:\/\/skeletalmusclejournal.biomedcentral.com\/articles\/10.1186\/s13395-020-00228-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,22]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["228"],"URL":"https:\/\/doi.org\/10.1186\/s13395-020-00228-3","relation":{},"ISSN":["2044-5040"],"issn-type":[{"value":"2044-5040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,22]]},"assertion":[{"value":"20 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures were approved by the University of Minnesota Institutional Animal Care and Use Committee and were performed in accord with the National Research Council\u2019s Guide for the Care and Use of Laboratory Animals (2011).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing financial interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10"}}